Biotech Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options August 26, 2026
Biotech CAPR Investor Losses: Capricor Therapeutics Clinical Data Announcement and Corresponding 64% Stock Drop Trigger Securities Class Action for Investors August 25, 2026
Biotech First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis August 24, 2026
Biotech Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding August 22, 2026
Biotech Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) August 22, 2026
Biotech Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 21, 2026
Biotech BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026 August 20, 2026
Biotech Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline August 20, 2026
Search
Biotech
August 26, 2026
August 26, 2026
August 26, 2026
August 25, 2026
August 24, 2026
August 22, 2026
August 22, 2026
August 21, 2026
August 20, 2026
August 20, 2026
